Question 1

What is Gossamer Bio?

Accepted Answer

Gossamer Bio is a Company.

Question 2

How often does Gossamer Bio appear in global news?

Accepted Answer

Tracked across 4 news events drawn from 306 articles.

Question 3

When was Gossamer Bio first tracked by Ergen?

Accepted Answer

First tracked on Apr 01, 2026.

Question 4

When was Gossamer Bio last mentioned in news?

Accepted Answer

Last active on Jun 17, 2026.

Question 5

What is Gossamer Bio's current news sentiment?

Accepted Answer

Aggregate sentiment score: -44 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Gossamer Bio in global news coverage?

Accepted Answer

Attention score of 6, derived from article volume and coverage intensity across 4 events.

Question 7

What is the most recent event involving Gossamer Bio?

Accepted Answer

Gossamer Bio PROSERA Study Failure Lawsuits (Apr 01, 2026, 228 articles).

Question 8

Who is Gossamer Bio most connected to?

Accepted Answer

Top relationships: The Law Offices of Frank R. Cruz, The Law Offices of Frank R. Cruz, Lawrence Rosen.

Question 9

How did the "Gossamer Bio PROSERA Study Failure Lawsuits" event impact Gossamer Bio?

Accepted Answer

Gossamer Bio is the defendant in multiple class action lawsuits following the failure of its Phase 3 PROSERA study, which led to an 80% drop in its stock price and potential delisting from Nasdaq-100. The lawsuits allege securities fraud due to undisclosed issues with the trial design.

Question 10

How did the "Gossamer Bio Completes Debt Exchange" event impact Gossamer Bio?

Accepted Answer

Gossamer Bio initiated an exchange offer for its Existing Convertible Notes to reduce debt and improve its financial structure, which is expected to have a positive impact on the company's financial health.

Question 11

How did the "Multiple Class Action Lawsuits Filed" event impact Gossamer Bio?

Accepted Answer

Gossamer Bio is subject to a class action lawsuit because its Phase 3 PROSERA study allegedly failed to meet its primary endpoint due to patient demographics at Latin American sites, leading to misleading positive statements.

Question 12

How did the "Howard G. Smith Files Multiple Class Actions" event impact Gossamer Bio?

Accepted Answer

Gossamer Bio is facing a class action lawsuit due to allegations that its Phase 3 PROSERA study failed to meet its primary endpoint, leading to misleading positive statements.

Question 13

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.